Skip to content

Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.

Correlation of Parathyroid Hyperplasia by Ultrasound With Clinical and Laboratory Findings in Patients With Chronic Kidney Disease.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03182517
Enrollment
30
Registered
2017-06-09
Start date
2018-02-01
Completion date
2018-11-30
Last updated
2018-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Brief summary

Secondary hyperparathyroidism is an important complication in patient with chronic kidney disease . It is associated with bone complication and an increase in cardiovascular mortality The parathyroid hormone rises in these patients as consequence of low concentration of vitamin D3 ,reduction in quantities of serum calcium, phosphorus retention and reduction of vitamin D receptors sensitive to calcium.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* stage 5 chronic renal failure * dialysis (peritoneal ,or hemodialysis) since 3---5 years

Exclusion criteria

* previous of neck surgery. * Patients refusal to participate in the study or voluntary withdrawal

Design outcomes

Primary

MeasureTime frameDescription
The percentage of patients with high parathyroid hormone level1 daylaboratory measurement of parathyroid hormone

Countries

Egypt

Contacts

Primary ContactAhmed Abbas
bmr90@hotmail.com01003385183
Backup ContactAhmed Abbas

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026